GV 2019 GP, L.L.C.'s Net Worth
$0
Estimate Recalculated Nov 1, 2024 06:31AM EST
Who is GV 2019 GP, L.L.C.?
GV 2019 GP, L.L.C. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include IonQ, Inc., Verve Therapeutics, Inc., Decibel Therapeutics, Inc., and Prime Medicine, Inc..
SEC CIK
GV 2019 GP, L.L.C.'s CIK is 0001845038
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
dMY Technology Group, Inc. III (IONQ) Snapshot price: $6.792
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Prime Medicine, Inc. (PRME) Snapshot price: $3.4303
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.10% | -112.82K |
$15.02 | -$847,744.04 | 10.1M |
Jun 20 - Jun 21
| |||
Form 4
| -1.42% | -146.38K |
$14.97 | -$1,092,434.97 | 10.16M |
Jun 15 - Jun 16
| |||
Form 4
| -1.10% | -114.12K |
$15.00 | -$855,786.85 | 10.23M |
Jun 13 - Jun 14
| |||
Form 4
| -0.61% | -63.41K |
$14.73 | -$467,134.63 | 10.29M |
Jun 9 - Jun 12
| |||
Form 4
| -0.39% | -40.00K |
$16.33 | -$332,557.00 | 10.32M |
Jun 7 - Jun 8
| |||
Form 4
| -1.00% | -104.82K |
$16.86 | -$884,777.42 | 10.34M |
Jun 5 - Jun 6
| |||
Form 4
| -1.18% | -123.71K |
$14.01 | -$876,197.61 | 10.39M |
May 31 - Jun 1
| |||
Form 4
| -0.56% | -58.81K |
$13.70 | -$402,843.55 | 10.45M |
May 26 - May 30
| |||
Form 4
| -0.59% | -62.12K |
$13.52 | -$417,893.25 | 10.48M |
May 24 - May 25
| |||
Form 4
| -2.45% | -263.72K |
$14.44 | -$1,889,739.36 | 10.51M |
May 22 - May 23
| |||
Form 4
| -1.55% | -167.54K |
$13.32 | -$1,230,337.74 | 10.65M |
May 18 - May 19
| |||
Form 4
| -0.61% | -65.65K |
$12.63 | -$829,275.47 | 10.74M |
May 16 - May 17
| |||
Form 4
| -1.69% | -185.24K |
$12.74 | -$2,359,308.93 | 10.8M |
May 12 - May 15
| |||
Form 4
| -1.03% | -114.02K |
$13.82 | -$1,575,337.42 | 10.99M |
May 10 - May 11
| |||
Form 4
| -3.66% | -422.01K |
$14.09 | -$5,946,340.40 | 11.1M |
May 8 - May 9
| |||
Form 4
|
∞
| 13.28M |
$17.00 |
—
| 13.28M |
Oct 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Verve Therapeutics, Inc. (VERV) Snapshot price: $5.595
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.39% | -145.75K |
$31.14 | -$3,025,610.98 | 10.37M |
Scheduled
|
Nov 4
| ||
Form 4
| -2.19% | -234.66K |
$34.23 | -$5,310,657.90 | 10.47M |
Scheduled
|
Nov 2 - Nov 3
| ||
Form 4
| -2.36% | -256.98K |
$37.79 | -$6,501,030.76 | 10.62M |
Scheduled
|
Oct 31 - Nov 1
| ||
Form 4
|
∞
| 4.47M |
—
|
—
| 4.47M |
Jun 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Decibel Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 819.63K |
—
|
—
| 819.63K |
Feb 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||